CatalystFDA/Bio

TROPION-Urothelial04 Phase 3 Trial of Datroway® Initiated as Adjuvant Therapy in Patients with High-Risk Muscle Invasive Urothelial Cancer

Phase 3 trial initiation marks clinical progress for Datroway in high-risk urothelial cancer.

What changed

Phase 3 trial initiation marks clinical progress for Datroway in high-risk urothelial cancer.

Why it matters

Phase 3 trial initiation marks clinical progress for Datroway in high-risk urothelial cancer. — impact context not separately stored; see What changed.

Sources

eodhd